Intramyocardial injection of vascular endothelial growth factor-A165 plasmid followed by granulocyte-colony stimulating factor to induce angiogenesis in patients with severe chronic ischaemic heart disease.
about
Gene therapy for ischemic heart diseaseGene Therapy in Cardiac Surgery: Clinical Trials, Challenges, and PerspectivesAdipose-derived mesenchymal stromal cells for chronic myocardial ischemia (MyStromalCell Trial): study designTherapeutic angiogenesis: controlled delivery of angiogenic factors.Improved Angiogenesis in Response to Localized Delivery of Macrophage-Recruiting MoleculesVEGF gene therapy: therapeutic angiogenesis in the clinic and beyondExperimental study of the effects of marrow mesenchymal stem cells transfected with hypoxia-inducible factor-1alpha geneAngiomyogenesis for myocardial repair.Stem cell therapy: pieces of the puzzle.Vascular endothelial growth factor signaling in hypoxia and inflammation.Update on gene therapy for myocardial ischaemia and left ventricular systolic dysfunction or heart failure.Gene targeting in ischemic heart disease and failure: translational and clinical studies.Controlled release systems of angiogenic growth factors for cardiovascular diseases.G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models.Biological approaches to ischemic tissue repair: gene- and cell-based strategies.Myocardial repair: from salvage to tissue reconstruction.Cell therapy for ischaemic heart disease: focus on the role of resident cardiac stem cells.Update on therapeutic vascularization strategies.Human studies of angiogenic gene therapy.Toll-like receptor 3 plays a role in myocardial infarction and ischemia/reperfusion injury.Transplantation of endothelial progenitor cells as therapeutics for cardiovascular diseases.Evaluation of mobilized peripheral blood CD34(+) cells from patients with severe coronary artery disease as a source of endothelial progenitor cells.The use of soluble signals to harness the power of the bone microenvironment for implant therapeutics.Mesenchymal stromal cell and mononuclear cell therapy in heart disease.Mesenchymal stromal cells for cardiovascular repair: current status and future challenges.Non-viral gene therapy for myocardial engineering.Emerging medical treatment for angina pectoris.Therapeutic angiogenesis for the management of refractory angina: current concepts.Gene therapy and angiogenesis in patients with coronary artery disease.G-CSF for stem cell therapy in acute myocardial infarction: friend or foe?Concise review: Insights from normal bone remodeling and stem cell-based therapies for bone repairHematopoietic cytokines for cardiac repair: mobilization of bone marrow cells and beyond.Gene delivery methods in cardiac gene therapy.Stem cells therapy for cardiovascular repair in ischemic heart disease: How to predict and secure optimal outcome?Mechanistic, technical, and clinical perspectives in therapeutic stimulation of coronary collateral development by angiogenic growth factors.Percutaneous approaches for efficient cardiac gene delivery.Gene therapy for heart disease: molecular targets, vectors and modes of delivery to myocardium.Cardiovascular Gene Therapy: Past, Present, and Future.p53's choice of myocardial death or survival: Oxygen protects infarct myocardium by recruiting p53 on NOS3 promoter through regulation of p53-Lys(118) acetylation.Sonic hedgehog-induced functional recovery after myocardial infarction is enhanced by AMD3100-mediated progenitor-cell mobilization.
P2860
Q24632135-2D4A6876-7D1A-4A48-A47B-49D4E9056A00Q26769595-6D8A1B9F-F223-4E68-BCD8-FD361576B710Q26822936-946E3C8A-697E-4C8F-940B-BD2D74C872D2Q27023731-064D45F7-B400-404C-926F-2BCDD0C46DBDQ27303518-772323CA-B523-4E7B-8051-A10D7ECCDC15Q28260984-5DB54BA4-9F85-4C38-AF0B-AAE569135186Q30157205-9D3DE6F6-D927-45B4-85C2-A9AB00E5F82EQ30480151-9C78A433-6E17-4CD8-B5E8-08060E1DC588Q33348580-0ECEB912-F656-4391-8A50-43EAC399D71CQ33721685-ACFF4580-D1C7-46A7-8AF1-D1C47BDDD851Q35069886-CAA87AB0-B00B-4005-B352-CD8A86A9767AQ36617570-E40A4582-2C16-4FD3-B67E-CD17FCAF123CQ36985904-1700C9A2-21F8-4BF1-9D3C-5F499F7C76D6Q37149710-9B741E21-5F77-4A35-9151-3EC47A2F7D2BQ37176436-80054C62-4EA8-4658-B6CA-3C17535E1318Q37176440-DF28BDBC-5489-48A8-A4F7-CB88515D6FAAQ37206495-7A583AAB-AEEF-432E-92DB-9F3AF20AD15BQ37357266-12AA846A-EF5A-4157-AC98-A2BE8CD18174Q37406656-FE2F1526-3DDA-4EE6-B960-25E43FBC79C3Q37429806-4DBFD41C-1BBA-4EFC-91B6-DBF620CC6A1AQ37570669-0403CBAA-1B79-4317-A480-DDAED80683BFQ37572568-8DF35575-9F20-49A9-A359-9227C9BAB3FBQ37607007-D1D393E2-F288-4757-9412-CF53F34DFACAQ37608606-689DE604-EEA9-47C5-81E3-9B5F7A9AB207Q37626836-AF199734-600B-471C-AB19-9730A0CA6876Q37671758-849EDFD7-560B-4887-B4F5-9BBFE8BEAD91Q37729183-C10F83AB-A759-47FE-9060-FE754CBF4E11Q37734560-5F72FE0A-6D81-4A19-9620-FF0E6DFC8FC9Q37776515-BDA65786-132F-41F0-9E1A-5D2893E1D3CFQ37790168-E0504D01-49C9-4024-A8E4-E9F060AF1762Q37801614-A48A2FF2-145A-49D3-80A5-D0821E5B1997Q37871920-69C9D777-0931-49A4-A8A5-8C1238F3A01DQ37939775-EFCC7F18-EC73-43A5-AB7E-84F9F124030EQ38063950-6E4C17C2-6B21-40F2-B455-FA277C2A9B64Q38081027-46A90ABF-982C-4440-A766-AF3878CE4A68Q38113171-3D80BBF4-F8BB-4348-A252-E6CE79A80BCAQ38132253-801381D1-2536-4722-A0EB-02B6A853C0E2Q38733395-FC6C10A7-AA1D-4A75-879A-B953CEB15269Q42122625-593C7792-8BF8-4E96-B2BE-C3F53FA08DE3Q42762366-150071DA-1625-423A-BB4C-2AB98DF319CF
P2860
Intramyocardial injection of vascular endothelial growth factor-A165 plasmid followed by granulocyte-colony stimulating factor to induce angiogenesis in patients with severe chronic ischaemic heart disease.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Intramyocardial injection of v ...... ronic ischaemic heart disease.
@ast
Intramyocardial injection of v ...... ronic ischaemic heart disease.
@en
Intramyocardial injection of v ...... ronic ischaemic heart disease.
@nl
type
label
Intramyocardial injection of v ...... ronic ischaemic heart disease.
@ast
Intramyocardial injection of v ...... ronic ischaemic heart disease.
@en
Intramyocardial injection of v ...... ronic ischaemic heart disease.
@nl
prefLabel
Intramyocardial injection of v ...... ronic ischaemic heart disease.
@ast
Intramyocardial injection of v ...... ronic ischaemic heart disease.
@en
Intramyocardial injection of v ...... ronic ischaemic heart disease.
@nl
P2093
P356
P1476
Intramyocardial injection of v ...... hronic ischaemic heart disease
@en
P2093
Birger Hesse
Erik Jørgensen
Jens Kastrup
Yongzhong Wang
P304
P356
10.1093/EURHEARTJ/EHL117
P577
2006-07-06T00:00:00Z